Schedule 13G/A
RXRX Schedule 13G/A filing by State Street
State Street reported beneficial ownership of 12.9M shares, representing 12% of RECURSION PHARMACEUTICALS-A in this filing.
FiledOct 18, 2024
Ownership dateSep 30, 2024
Reported shares12.9M
Reported ownership12%
Ownership details
Voting and dispositive power reported in the filing
These figures describe the reporting filer’s disclosed voting and investment authority. They should be read together with the reported share count and percentage.
Sole voting power
12.3M
Shared voting power
12.3M
Sole dispositive power
12.9M
Shared dispositive power
12.9M
Price context
Price dates alongside the ownership filing
Price data provides market context around the disclosure. It does not identify the filer’s actual transaction price.
Close near filing date$6.94as of Oct 18, 2024
Latest tracked price$3.20as of Aug 5, 2026
Source
Original filing and accession
Use the SEC filing as the primary source when you need the complete disclosure, footnotes, exhibits, or reporting-person details.
- Reporting filer
- State Street
- CIK
- CIK0000093751
- Accession
- 0000093751-24-000871
- Form
- Schedule 13G/A
Read the filing in context